Vitamin D deficiency may be an indicator in the diagnosis of aggressive prostate cancer, according to researchers.
Breast and colorectalcancer patients with higher levels of vitamin D at the time of diagnosis may have better chances of survival and remain in remission longer those who are deficient, according to a scientific review.
A vitamin A form called retinoic acid that is commonly found in sweet potatoes and carrots, can help turn breast cells showing cancerous potential back to a healthy state, researchers have found.
When scientists seek to counteract bad press for omega-3s it is a matter of taking two steps forward while taking one back, said Bruce Holub, professor emeritus at the University of Guelph in Ontario.
The unique microbial composition of female breast tissue has given scientists new insight into the interaction between different bacteria in the human body and the effects this has on health.
Booming consumer demand for curcumin is driving an innovative but highly competitive supplier landscape, but Terry Lemerond, founder & president of EuroPharma,Inc., says his company has never talked down the competition, preferring to talk up their own product’s extensive science portfolio.
Folic acid is backed to deliver important health benefits in the scientific literature and by regulators – but is over-consumption a real problem? asks Robert Verkerk, PhD, the founder, executive and scientific director of the Alliance for Natural Health International (ANH-I) in this guest article.
Innovation in omega-3s has come in many forms. New delivery modes, new raw material sources, and new chemical forms. But through it all, the story has always been about EPA and DHA as whole molecules. That might be about to change.
The economic downturn has had a depressing effect on new product launches in the herbal dietary supplement industry, said Steve French, managing director of the Natural Marketing Institute. But the good news is that opportunity abounds, in that herbal supplement users are far more fiercely devoted to their products of choice than is the average supplement taker and younger consumers are the most enthusiastic of all.
Evidence for the nutrtional benefits of bioactives is steadily accumulating, and the time has come engage regulators in a process of determining dietary reference intakes (DRIs) for the best-researched substances, said Jim Griffiths, vice president of scientific and reglatory affairs for the Council for Responsible Nutrition.
Breast cancer patients with high levels of vitamin D in their blood are twice as likely to survive the disease as those with lower levels, new research has suggested.
The makeup of microbes living in our gut may be a risk factor for colorectal cancer and could drive the development of intestinal tumours, say researchers.
Biomimicry, or the practice of taking cues from nature for design of products for human use, could transform the way dietary supplments manufacturers interact with their consumers, an expert says.
The final report from a government task force finding no preventive effect of multivitamin usage in relation to cancer and cardiovascular disease has been modified in an appropriate way to reflect the tight focus of the review, said the Council for Responsible Nutrition. How the report will be written about in the mainstream press remains to be seen.
Influential figures in the herbal sphere aren’t always involved in what most would term “natural” products. So it is with Gordon M Cragg, PhD, the latest recepient of a prominent award from the American Botanical Council.
Biothera, a company long known for an extensive research program backing both its nutraceutical and pharmaceutical ingredients derived from bakers yeast, has completed a mode of action study on its Wellmune dietary supplement ingedient.
MegaFood, a leading manufacurer of whole food supplements, has teamed up with an organic orange juice supplier for a ‘grove to tablet’ line of vitamin C supplements.
The Federal Trade Commission has filed a long awaited brief in POM Wonderful’s appeal of a false advertising case against the company. As expected, FTC contends that POM’s ads were deceptive, and the company lacked sufficient clinical data to back up its far-reaching claims on its products and that First Amendment protections do not apply.
Once again, negative results from a tightly focused study with a nutraceutical ingredient have been generalized in the mainstream media as a blanket condemnation. In this case, it was the news that megadoses of vitamin E fed to cancer-prone mice caused their tumors to grow faster. Despite the hubbub, it’s news that is, as far as human supplementation is concerned, “irrelevant,” said Duffy MacKay of the Council for Responsible Nutrition.
A paradigm shift is needed in the study of polyphenols to better understand the bioavailability, bio-activity, and the role of the gut microbiota in polyphenol metabolism and health benefits, say experts from academia and industry.
A recent human clinical trial showed that oral supplementation of Setria® glutathione (GSH) increased levels of GSH in the...
INNOBIO® Astaxanthin is naturally sourced from Haematococcus pluvialis. INNOBIO offers a variety of astaxanthin products manufactured...
NMI found that 35% of U.S. shoppers say non-GMO is a concern to them. That’s up from 25% two years ago. In this webinar you will learn...